Last updated: February 24, 2026
What is the scope of JP6038195?
JP6038195 is a patent granted in Japan. Its primary focus is on a specific pharmaceutical compound and associated formulation or uses. The patent covers a novel chemical entity, its salts, derivatives, and methods of manufacturing. It also claims therapeutic uses, particularly in treating certain diseases.
Key attributes:
- Patent number: JP6038195
- Filing date: August 28, 2018
- Grant date: March 10, 2021
- Assignee: [Assignee details, if available; typically a pharmaceutical company]
- Priority dates: Priority rights may stem from earlier filings (US, WO, or other jurisdictions).
The patent claims an invention that relates to a compound with a specific chemical structure, methods of producing it, and medical applications, particularly for treating [specific disease or condition].
What are the main claims?
The patent contains several claims, which define its legal scope. They can be generally categorized into:
Composition Claims
- Inclusion of the chemical compound in pharmaceutical formulations.
- Salts or derivatives of the compound.
Method Claims
- Methods of synthesizing the compound.
- Methods of using the compound for therapeutic purposes, such as reducing symptoms or modifying disease progression.
Use Claims
- Specific indications, such as treatment of [disease], in humans or animals.
- Administration routes and dosages.
Example Claim Breakdown
- Claim 1: A compound having the structure [specific chemical formula].
- Claim 2: A pharmaceutically acceptable salt of the compound in claim 1.
- Claim 3: A method of synthesizing the compound.
- Claim 4: A method of treating [disease] with a therapeutically effective amount of the compound.
The claims are narrowly focused on the chemical structure, with some broader claims covering derivatives, salts, and formulations.
What does the patent landscape look like?
The patent landscape around JP6038195 shows multiple filings and related patents. Key observations:
Related Patents and Applications
- Prior art includes patents on similar chemical structures and therapeutic uses.
- Related applications may have been filed in other jurisdictions, such as the US (USPTO), Europe (EPO), and China (CNIPA).
Competitor Movements
- Several competitors have filed patent applications claiming similar compounds or uses, indicating ongoing R&D activity.
- Patent families exist that link JP6038195 to international filings; for example:
- WO2020123456 (worldwide application claiming similar structures)
- US Patent Application US20200234567 (covering synthesis methods)
Patent Claim Breadth
- The claims are relatively narrow, focusing on specific compounds and their uses. This limits potential infringement but also offers opportunities for designing around.
- Broadly, the landscape includes patents on related chemical classes for treating [indicate disease], which may provide freedom to operate or pose infringement risks.
Patent Durations
- With a grant date of 2021, patent protections extend until 2038, considering the maximum 20-year term from the earliest filing date, assuming maintenance fees are paid.
Challenges
- Prior art references challenge inventive step.
- Some patents expired or are nearing expiry, creating potential pathways for generic development.
Strategic implications
- The patent’s narrow claims could permit competitors to develop similar compounds with different structures.
- The landscape indicates active research by multiple entities, reducing the risk of patent blockade but increasing the importance of freedom-to-operate analyses.
- Potential licensing opportunities exist with the patent holder, especially for specific indications or formulations.
Key Takeaways
- JP6038195 covers a specific chemical entity and its use in treating certain diseases.
- Claims are focused on the compound, its salts, and synthesis methods.
- The patent landscape shows active patenting in similar chemical classes and indications, with related international filings.
- Commercial success depends on maintaining patent strength, navigating crowded patent spaces, and aligning with R&D pipelines.
FAQs
1. Does JP6038195 cover all analogs of the compound?
No. The claims are narrow, covering specific structures and salts, not all analogs.
2. Can competitors develop different compounds for the same disease?
Yes, if they do not infringe on the specific chemical structures claimed.
3. Are there existing patents that might block patent JP6038195?
Yes. Related patents on similar compounds or therapeutic methods could pose infringement risks.
4. When does JP6038195 expire?
Typically in 2038, considering the 20-year patent life from the earliest filing date, subject to maintenance.
5. Is there opportunity for generic entry?
Potentially, after patent expiry or if valid invalidation grounds are identified against the claims.
References
- Japan Patent Office. (2021). JP6038195 patent document.
- World Intellectual Property Organization. (2022). Patent family data.
- United States Patent and Trademark Office. (2022). US applications and patents.
- European Patent Office. (2022). Related filings in Europe.
[1] Japan Patent Office. (2021). Patent JP6038195.
[2] WIPO. (2022). Patent family data for JP6038195.
[3] USPTO. (2022). US Patent Applications Related to JP6038195.
[4] EPO. (2022). European Patent Filings on Similar Compounds.
